Un arall o’r argymhellion oedd adolygu’r meini prawf y mae panel IPFR corff GIG yn eu defnyddio i asesu IPFR drwy ei wneud yn ofynnol i’r clinigwr ddangos yr enillai claf fudd clinigol arwyddocaol am werth rhesymol am arian i GIG Cymru, yn hytrach na dangos bod gan glaf eithriadoldeb clinigol. Yr adroddiad blynyddol diweddaraf am y broses IPFR (https://www.awttc.org/ipfr) yw’r cyntaf ar gyfer blwyddyn lawn ers adolygu’r canllawiau IPFR ym mis Mehefin 2017.
Another of the recommendations was to revise the criteria an NHS organisation’s IPFR panel use to assess an IPFR by requiring the clinician to show a patient would gain significant clinical benefit at reasonable value for money for the NHS, rather than showing that a patient had clinical exceptionality. Thelatest annual report about the IPFR processis the first to cover a full year since the IPFR guidance was revised in June 2017.